Alexandra Collingbourne Alexandra Collingbourne

Arecor goes from strength to strength

Upbeat Arecor Therapeutics, the Cambridge biopharma company, reveals it is continuing discussions with potential partners to expand its portfolio of revenue generating partnership deals.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Flusso engineer wins major research award

Dr Ethan Gardner, one of the youngest R & D engineers with Cambridge-based fabless semiconductor company Flusso – a Cambridge University spin-out – has won a major UK honour.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery

Axol Bioscience Ltd., an established provider of iPSC-derived cells, media, and characterization services for life science discovery, announces that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation.

Read More